Avalo Therapeutics, Inc. · NASDAQ:AVTX

Ra Capital Management, L.P. reported a 9.90% stake in Avalo Therapeutics, Inc. (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

Ra Capital Management, L.P. reported a 9.90% stake in Avalo Therapeutics, Inc., 1,386,167 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
9.90%
Shares
1,386,167
Intent
Passive
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
RA Capital Management, L.P.9.90%1,386,167
Peter Kolchinsky9.90%1,386,167
Rajeev Shah9.90%1,386,167
RA Capital Healthcare Fund, L.P.9.90%1,386,167

Source

View original at SEC

Related